NCT00014469 Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic Cancer Status COMPLETED Phase PHASE2
NCT00010283 Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon Status COMPLETED Phase PHASE1/PHASE2
NCT00008307 Combination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Genetic Disorders Status UNKNOWN Phase PHASE2
NCT00008216 Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer Status TERMINATED Phase N/A
NCT00008164 Umbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia Status UNKNOWN Phase PHASE2
NCT00008151 Gemtuzumab Ozogamicin, Fludarabine, and Total-body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome Status COMPLETED Phase PHASE2
NCT00006350 Mycophenolate Mofetil, Tacrolimus, Daclizumab, and Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer Status COMPLETED Phase PHASE2
NCT00006348 Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment Status COMPLETED Phase PHASE3
NCT00006239 Phenylbutyrate and Tretinoin in Treating Patients With Hematologic Cancer Status COMPLETED Phase PHASE1
NCT00006220 Arsenic Trioxide With or Without Tretinoin in Treating Patients With Hematologic Cancer That Has Not Responded to Previous Therapy Status TERMINATED Phase PHASE1/PHASE2
NCT00006083 Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter Status COMPLETED Phase PHASE3
NCT00006042 Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer Status COMPLETED Phase PHASE1
NCT00006040 Radiolabeled Monoclonal Antibody Therapy and Etoposide Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Myelodysplastic Syndrome or Refractory Leukemia Status COMPLETED Phase PHASE1
NCT00006019 Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate Cancer Status COMPLETED Phase PHASE2
NCT00005988 Bone Marrow Transplantation With Specially Treated Bone Marrow in Treating Patients With Hematologic Cancer That Have Not Responded to Previous Therapy Status COMPLETED Phase PHASE1
NCT00005967 Tipifarnib in Treating Patients With Advanced Hematologic Cancer Status COMPLETED Phase PHASE1
NCT00005946 Chemotherapy Plus Donor White Blood Cell Infusion in Treating Patients With Relapsed Hematologic Cancer Following Donor Peripheral Stem Cell Transplantation Status COMPLETED Phase PHASE1
NCT00005892 Study of Allogeneic Bone Marrow Transplantation Following Cyclophosphamide and Radiotherapy in Patients With Myelodysplastic Syndrome and Acute Leukemia Related to Fanconi's Anemia Status COMPLETED Phase NA